ABOUT DEC GROUP
Dec Group is the leading global provider of contained powder handling systems and is recognized as a world-leading expert in process containment technologies. It has been supplying the pharmaceutical, chemical, food and cosmetic industries for more than 35 years.
The depth of Dec’s knowledge and their ability to develop innovative new technologies make them an invaluable partner for both multinationals and specialist organizations.
With true worldwide coverage through subsidiaries in Switzerland, Germany, Great Britain, Ireland, Netherlands, Poland, USA, India, China, its recent acquisition of advanced containment and aseptic solution provider Extract Technology and the latest expansion with the integration of UK based Alconbury Weston Ltd (AWL), leading in flow chemistry solutions as well as agents covering more than 60 countries, the Dec Group provides its customers with unparalleled global expertise and a reliable network for local support.
1118 Industrial Pkwy.
Brick, NJ 08724
Phone: (732) 202-7536
Contact: Andrew Milner
Dual-Chamber Syringes (DCS) are in high demand across the pharmaceutical and hospital industries. Learn about the challenges of the DCS filling manufacturing market and how to overcome them.
Recently, Dec Group has successfully implemented a fully automated Blood Bag Processing System (BBPS) at Sanquin, a not-for-profit based organization responsible for the safe and efficient blood supply in the Netherlands.
Powder handling and process specialist Dec Group will show innovative flow chemistry solutions with recently acquired UK-based Alconbury Watson (AWL) and various handling and processing technologies at the ACHEMA 2022 expo held in Frankfurt from August 22 - 26.
We are very pleased to announce the recent acquisition of UK-Stoke-on-Trent based AWL, one of the most dedicated companies for the design, manufacture and supply of continuous processing technologies and systems. Over the past decade, they have translated the much-debated ideas of continuous processing into reality for current use in the chemical, food and pharmaceutical industries by offering solutions from laboratory evaluation systems to production scale turnkey systems.
Extract Technology and the Dec Group (Dietrich Engineering Consultants) announce a significant expansion of their UK ISO 9001 manufacturing facility located in Huddersfield, UK. The Bradley Junction site expansion includes the acquisition of an additional building within the current industrial complex.
Best Practices For The Design And Manufacture Of Radiopharmaceutical Containment Hot Cells, Isolators, And Gloveboxes
In this article we address a number of OHS, regulatory and process requirements imperative to the delivery of critical containment systems.
Achilles Therapeutics sources a customized aseptic processing solution to safely process irreplaceable personalized T-cell therapies.
Extract Technology And Dec Group Announce Manufacturing Facility Expansion In Wisconsin To Meet Production Needs
Extract Technology and the Dec Group announce production expansion to existing Midwest, USA operations! Extract’s New Lisbon, WI manufacturing operations will see expansion to a new, renovated Midwest site in neighboring Mauston, WI. The facility and investment provides a fantastic opportunity for optimizing manufacturing layout, capital equipment upgrades and creating a customer focused environment with potential for future expansion as we grow the Dec Group and Extract businesses.
Read about a new generation of spiral jet mills meeting specific particle size distribution (PSD) targets that has been developed.
The earliest uses of aseptic isolators were for sterility testing. Sterility test isolators make up most of the aseptic isolators in use and are available in many different sizes and configurations.
Cell and gene therapies are currently produced in facilities that require significant upfront investment and high per patient cost. The future of facility design is leaning on pillars including automation and innovation to reshape the way we use fixed assets and the production process as a whole. Integration of closed processes such as isolators into the largely human workflow is an increasingly effective method to adopt production efficiency that improves patient safety and reduces contamination along with overall costs.
Earlier today, The Dec Group completed the acquisition of the Extract Technology business from US based Wabash National Corporation, a US listed company (NYSE: WNC).
Powder handling and high containment specialists Dec Group has announced the appointment of Intrepid Bioprocess Technologies as their US agent for the Westcoast including California, Oregon and Washington.
Although most current legislation concerning traceability of pharma products focuses on serialization rather than aggregation, the latter is an essential component of internal and external traceability of products.
Pharmaceutical manufacturing staff, equipment and premises are all subject to stringent quality controls. Read more about the latest status, trends and technologies in parenteral filling equipment.
Dec will participate in the 2020 PDA Universe of Pre-Filled Syringes and Injection Devices event held October 5 – 8. This year's conference will be held virtually. It offers industry expertise by sharing new developments and trends in this continuously growing market while also reflecting on regulatory matters and common challenges.
Over more than three decades, Dec Group has brought innovation to the pharmaceutical process industry by introducing active versus gravity charging and process linking with its Powder Transfer System (PTS), a unique solution that uses both pressure and vacuum to ensure all forms of dry powders and granules flow efficiently and safely between processes and containers.
Due to the high potency of APIs, machine operators must be protected. Yet, humans are a high source of product contamination. In pharma manufacturing facilities, isolators are becoming increasingly important.
A customer had planned a new facility for the production of intravenous liquids. They were facing a challenge of charging multiple vessels with salt, glucose and active carbon under controlled conditions achieving high accuracy. See what solution allowed them to create a highly automated high capacity facility.
A facility handled sterile blending and packing powder from a tilting filter dryer under sterile conditions. They were transferring the discharge of the tilting dryer by screw feeder and transferring into an agitated mixer. Discharging the mixer by a screw feeder into a packing system. They were encountering sterility loss through mechanical seals and docking of the dryer to the screw feeder and difficulties to clean and sterilize the system in place. A solution was a full automatice system including a transfer system, batchmixer and sampling device.
An operation required manual filling of IBCs by using a flexible isolator installed on an upper floor with large amounts of excipients (lactose and micro cellulose)> 100 kg and only a small amount of APls of a few kilos. Operation was strenuous due to the large quantity of excipients to be handled in the isolator which lead to the damage of the flexible isolator and containment breach. Several equipment and process changes allowed them to see an increase of plant productivity.
A multipurpose facility for API production had various requirements including milling, micronizing, packaging, and the possibility to blend various batches together before or after milling.
The increasing toxicity and reactivity of API products and more demanding production standards have made closed powder handling an unavoidable factor and manual handling obsolete.
By reviewing and evaluating the health and safety data for each product involved in the manufacturing process this supplier was able to determine that the correct containment solution.
Cell and gene therapies are currently produced in fixed facilities that require a significant upfront investment. Modular concepts offer an opportunity to shift from these large, fixed assets.
The move from sterility testing within LAF safety cabinets to those in aseptic isolators has resulted in a marked decrease in false positives.
To allow a pharma facility to maintain regulatory compliance with ISO 5 conditions ensuring product protection, a positive to ambient pressure regime was used within the airlocks.
As isolators become more customized to meet the requirements of specific Pharmaceutical processes, the controls systems have been challenged to provide more safety and flexibility.
Uses of isolators for aseptic processing are far reaching. The earliest use of aseptic isolators were for sterility testing. Sterility test isolators make up most of aseptic isolator use and are available in many different sizes and configurations.
These days several Pharmaceutical companies are moving to single use, flexible film isolators for containment of potent compounds during Pharmaceutical processing. Flexible film isolators have also been used for aseptic processes, like sterility testing.
While price is certainly an important reason for buying any piece of capital equipment, it is not always the top reason. There are important considerations to examine when selecting an isolator supplier.
The mobile clean room is a self-contained manufacturing space fully constructed off-site. It is shipped to customer facility on a double drop flatbed trailer in one piece and ready to hook up.
This document provides an overview on how to properly validate sterility test isolator systems and then, via a case study, describes a strategy for streamlining the validation process when equivalent isolators and/or generators are installed in a sterility test suite. By James R. Rickloff, Partner/Scientific Director Advanced Barrier Concepts, Inc.
- Overcoming Aseptic Manufacturing Challenges To Prevent Contamination
- DecFill® Aseptic Filling Line – Modular And Flexible Solutions
- 10 Advantages Of MC DecJet® Micronization
- Mobile Clean Room Solutions
- Pharmaceutical Packaging Serialization Integration Partner
- Pharmaceutical Packaging Serialization Equipment
- Pharmaceutical Packaging Item Serialization Units
- Pharmaceutical Packaging Case Serialization Units
- Lyophilization (Un)Loading Equipment Solutions
- Primary Packaging Filling Lines And Containment Units
- Aseptic Fill-Finish Solutions
- Transbatch Transfer System With High Containment Vacuum And Pressure
- Suction Hoppers
- Single Charge Container - Small Powder Charging
- SafeDock - Connection And Containment System
- Safe Handling Of Toxic And Corrosive Liquids
- R&D Micronizer MC DecJet 30®
- PTS Powder Transfer System® CIP SIP Hygienic Design
- PTS Powder Transfer System
- PTS Powder Transfer System Mobile Version
- PTS Batchmixer High Containment Powder Mixer
- Production Scale Micronizer MC DecJet® 200
- Powderflex - Combined System For Conveying And Dosing Powders
- Pilot Scale Micronizer MC DecJet® 150
- Pilot Scale Micronizer MC DecJet® 100
- Packing Of High Potent APIs
- MPTS - Safe Sampling Of Toxic Or Explosive Powders
- MC DecJet® 300 Production Jet Mill
- MC DecJet® 50 Jet Mill Micronizer
- MC DecJet 400 Micronizer, Micronizing Up To 300 kg
- Lump Breaker Suction Lance
- Isotube - High Containment Drum Emptying
- High Containment Bag Handling And Process Charging
- Isolator Glove Integrity Tester
- Isocharge For Drums - High Containment Of Powders Out Of Drums
- Flexible Isolator System
- Filter Dryer Discharge Isolator
- Fast, Precise Dosing Of Powders
- Drum Containment And Big Bag Filling System
- Dosing Valve For Powders And Granules
- DCS Drum Containment System
- Crushing Of Agglomerated Products
- Bag And Drum Filling CLS Continuous Liner System
- Big Bag Filling
- Big Bag Discharging
- Powder Discharging Systems For Non-Potent To High Potent Active Ingredients
- Dust Free And Accurate Filling Of Flexible Intermediate Bulk Containers
- Integrated Containment Solutions For Potent And Aseptic Operations
- Powder Handling & Process Containment Solutions From A Single Source
- Pharmaceutical And Chemical Powder Micronization
A fully automated Blood Bag Processing System (BBPS) a Dutch blood supply organization is completely tailor-made with an ergonomic design custom-made to the workflow requirements of the blood bank.
This video highlights Dec’s high containment micronizing technology and materials handling systems. See how a complex two-floor large scale high containment micronizing plant equipped with fully contained sampling and pack-off technology solutions ensure OEL levels are kept well under the target while allowing fully streamlined processes.
A discussion on aseptic pharmaceutical packaging process challenges that need to be addressed in the final filling process of dual chamber syringes, where both liquid and powdery substances are mixed by the patient immediately prior to injection.
This online event will give you the opportunity to gain insight into process innovation, occupational health and safety questions, and appropriate technologies available today to overcome the many challenges in high-containment manufacturing facilities.
Dec Group is your partner in powder handling and process contamination technologies. With locations around the globe we have over 30 year of experience in contained and sterile powder handling solutions. This video highlights our capabilities and our state-of-the-art solutions for sophisticated risk management.- Dec Group is your partner in powder handling and process contamination technologies. With locations around the globe we have over 30 year of experience in contained and sterile powder handling solutions. This video highlights our capabilities and our state-of-the-art solutions for sophisticated risk management.
How do you quickly implement a new state-of-the-art modular high-potency pharmaceutical manufacturing plant and take the opportunity to integrate the latest patient delivery systems?